Haddadin Yezan Munther
Insider CIK 1718004 · ONS Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| OTLK Outlook Therapeutics, Inc. | P Buy | 2026-06-02 | 2026-06-03 | 29,000 | $0.83 | $24.1K | 66,167 | SEC↗ |
| OTLK Outlook Therapeutics, Inc. | P Buy | 2026-05-26 | 2026-05-27 | 34,000 | $0.44 | $15.0K | 37,167 | SEC↗ |
| OTLK Outlook Therapeutics, Inc. | A Award deriv | 2025-10-03 | 2025-10-03 | 95,969 | — | $0 | 95,969 | SEC↗ |
| OTLK Outlook Therapeutics, Inc. | A Award deriv | 2025-10-01 | 2025-10-03 | 286,734 | — | $0 | 286,734 | SEC↗ |
| OTLK Outlook Therapeutics, Inc. | A Award deriv | 2024-10-03 | 2024-10-03 | 19,771 | — | $0 | 19,771 | SEC↗ |
| OTLK Outlook Therapeutics, Inc. | A Award deriv | 2024-10-01 | 2024-10-03 | 132,293 | — | $0 | 132,293 | SEC↗ |
| OTLK Outlook Therapeutics, Inc. | A Award deriv | 2024-10-01 | 2024-10-03 | 56,636 | — | $0 | 56,636 | SEC↗ |
| OTLK Outlook Therapeutics, Inc. | P Buy | 2024-03-28 | 2024-03-29 | 1,882 | $11.82 | $22.2K | 5,049 | SEC↗ |
| OTLK Outlook Therapeutics, Inc. | A Award deriv | 2024-03-07 | 2024-03-08 | 94,441 | — | $0 | 94,441 | SEC↗ |
| OTLK Outlook Therapeutics, Inc. | A Award deriv | 2023-10-04 | 2023-10-05 | 358,337 | — | $0 | 358,337 | SEC↗ |
| OTLK Outlook Therapeutics, Inc. | A Award deriv | 2023-03-29 | 2023-03-31 | 41,065 | — | $0 | 41,065 | SEC↗ |
| OTLK Outlook Therapeutics, Inc. | P Buy | 2022-10-07 | 2022-10-11 | 3,600 | $1.27 | $4.6K | 63,343 | SEC↗ |
| OTLK Outlook Therapeutics, Inc. | P Buy | 2022-10-06 | 2022-10-11 | 29,743 | $1.29 | $38.4K | 59,743 | SEC↗ |
| OTLK Outlook Therapeutics, Inc. | A Award deriv | 2022-10-05 | 2022-10-07 | 71,998 | — | $0 | 71,998 | SEC↗ |
| OTLK Outlook Therapeutics, Inc. | A Award deriv | 2022-03-23 | 2022-03-24 | 21,878 | — | $0 | 21,878 | SEC↗ |
| OTLK Outlook Therapeutics, Inc. | P Buy | 2021-12-02 | 2021-12-02 | 10,000 | $1.39 | $13.9K | 30,000 | SEC↗ |
| OTLK Outlook Therapeutics, Inc. | A Award deriv | 2021-10-05 | 2021-10-07 | 47,335 | — | $0 | 47,335 | SEC↗ |
| OTLK Outlook Therapeutics, Inc. | P Buy | 2021-04-19 | 2021-04-20 | 10,000 | $1.82 | $18.2K | 20,000 | SEC↗ |
| OTLK Outlook Therapeutics, Inc. | A Award deriv | 2021-03-24 | 2021-03-26 | 20,873 | — | $0 | 20,873 | SEC↗ |
| OTLK Outlook Therapeutics, Inc. | A Award deriv | 2020-10-05 | 2020-10-05 | 160,474 | $0.51 | $81.8K | 160,474 | SEC↗ |
| OTLK Outlook Therapeutics, Inc. | A Award deriv | 2020-10-01 | 2020-10-05 | 290,372 | — | $0 | 290,372 | SEC↗ |
| OTLK Outlook Therapeutics, Inc. | P Buy | 2020-09-22 | 2020-09-22 | 10,000 | $0.72 | $7.2K | 10,000 | SEC↗ |
| OTLK Outlook Therapeutics, Inc. | A Award deriv | 2020-07-17 | 2020-07-21 | 135,000 | — | $0 | 135,000 | SEC↗ |
| OTLK Outlook Therapeutics, Inc. | A Award deriv | 2020-03-19 | 2020-03-20 | 15,000 | — | $0 | 15,000 | SEC↗ |
| OTLK Outlook Therapeutics, Inc. | A Award deriv | 2020-01-02 | 2020-01-06 | 5,980 | $0.99 | $5.9K | 5,980 | SEC↗ |
| OTLK Outlook Therapeutics, Inc. | A Award deriv | 2019-10-03 | 2019-10-07 | 15,000 | — | $0 | 15,000 | SEC↗ |
| OTLK Outlook Therapeutics, Inc. | A Award deriv | 2019-10-03 | 2019-10-07 | 80,176 | $0.99 | $79.4K | 80,176 | SEC↗ |
| ONS Oncobiologics, Inc. | A Award deriv | 2017-10-31 | 2017-11-02 | 25,000 | — | $0 | 25,000 | SEC↗ |